MiR-224-5p regulates colorectal cancer chemoresistance by modulating autophagy via BCL2

1.Supplementary Figure 1 Clinical relevance of the miR-224-5p/BCL2 axis in CRC tissues from TCGA cohort 2.Supplementary Figure 2 MiR-224-5p enhances the sensitivity of chemotherapy-resistant CRC cells to oxaliplatin or 5-FU3.Supplementary Figure 3 MiR-224-5p inhibit autophagy in chemotherapy-resistant CRC cells4.Supplementary Figure 4 MiR-224-5p enhances the sensitivity of chemotherapy-resistant CRC cells to oxaliplatin or 5-FU by inhibiting BCL25.Supplementary Figure 5 MiR-224-5p inhibit autophagy in chemotherapy-resistant CRC by inhibiting BCL2